ipatasertib,atezolizumab
roche
['prostate', 'congrat', 'icecap']
#asco23 psa &gt; or equal to 0.1 ng/ml six months after radiation rx with or without adt for localized #prostatecancer highly prognostic for outcomes. multiple implications on clinical practice and future trials. congrats to icecap investigators 
Medical Oncologist. Editor-in-chief: @ASCO Daily News; Presidential Endowed Chair, @HuntsmanCancer (NCI-CCC) @UUtah, FCOI https://t.co/ywWAdZmBWt